Secukinumab in pityriasis rubra pilaris: A case series demonstrating variable response and the need for minimal clinical datasets

Tevi Wain; Bonita Choy; Andrew C Satchell; Jane A Woods; John W Frew

doi:10.1016/j.jdcr.2018.02.007

Secukinumab in pityriasis rubra pilaris: A case series demonstrating variable response and the need for minimal clinical datasets

JAAD Case Rep. 2018 May 7;4(5):500-505. doi: 10.1016/j.jdcr.2018.02.007. eCollection 2018 Jun.

Authors

Tevi Wain¹, Bonita Choy², Andrew C Satchell³, Jane A Woods^{2

4}, John W Frew^{2

4

5}

Affiliations

¹ Department of Dermatology, Concord Hospital, Sydney, Australia.
² Department of Dermatology, Liverpool Hospital, Sydney, Australia.
³ University of Sydney, Sydney, Australia.
⁴ Ingham Institute for Applied Medical Research, Sydney, Australia.
⁵ University of New South Wales, Sydney, Australia.

No abstract available

Keywords: CLL, chronic lymphocytic leukemia; IL, interleukin; PRP, pityriasis rubra pilaris; interleukin-17A; minimal clinical dataset; pathogenesis; pathophysiology; pityriasis rubra pilaris; secukinumab; taxonomy.

Publication types

Case Reports